C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2006
11/07/2006	US7132539 Melanocortin receptor ligands
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132419 Benzo[a]phenazine-11-carboxamide derivative used as fungicide, bactericide, inhibitors of topoisomerase for treating cancer
11/07/2006	CA2186023C Process for preparing 2-piperazine carboxylic acid derivatives
11/02/2006	WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/02/2006	WO2006115652A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006061215A3 2-alkyl-cycloalk(en)yl-carboxamides
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247248 Sigma-1 receptor ligand with acetylcholinesterase
11/02/2006	US20060247244 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060246099 Compositions containing piperazine compounds
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	CA2606410A1 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
11/02/2006	CA2605480A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/01/2006	CN1856467A 2-pyridone derivatives as netrophil elastase inhibitors and their use.
11/01/2006	CN1856309A Hexa- and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
11/01/2006	CN1854137A Method for resoluting zopiclone
11/01/2006	CN1854129A Superhigh purity ionic liquid
11/01/2006	CN1282647C Preparation method of acymose
11/01/2006	CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
10/2006
10/31/2006	US7129354 1-(3-(2-pyridinyloxyethoxy)-2-pyrazinyl)-2-methylpiperazine acid salt derivatives, their preparation and use as serotonin receptor modulators
10/31/2006	US7129234 Selective serotonin re-uptake inhibitors
10/31/2006	US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/26/2006	WO2006111716A1 Heteroaryl derivatives having anti-mycobacterial activity
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	US20060241121 Substituted piperazines as CB1 antagonists
10/26/2006	US20060241118 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	DE102005017116A1 Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) Inhibitors of inhibitors of apoptosis proteins (IAP)
10/26/2006	CA2601979A1 2,3 substituted pyrazine sulfonamides
10/25/2006	EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006	CN1850808A Non oxaza organics and their use
10/25/2006	CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/24/2006	US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/19/2006	WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof
10/19/2006	WO2006108712A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
10/19/2006	WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006	WO2006050964A3 Indinavir derivatives useful in immunoassay
10/19/2006	US20060235226 Synthesis of diketopiperazines
10/19/2006	US20060235220 Dipeptide nitriles
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006	US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
10/19/2006	US20060235014 Inhibitors of p38
10/19/2006	CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof
10/19/2006	CA2602197A1 Inhibitors of akt activity
10/19/2006	CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006	CA2598208A1 Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
10/18/2006	EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006	EP1027397B1 Electrochrome polymer systems
10/18/2006	CN1849121A Piperazine derivatives as bradyknin antagonist
10/18/2006	CN1847253A Process for preparing amine platinum complexes
10/18/2006	CN1847230A Water soluble cinnarizine salt and its injection form
10/18/2006	CN1280292C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling
10/12/2006	WO2006048750A3 Novel compounds of substituted and unsubstituted adamantyl amides
10/12/2006	US20060229319 For treatment of allergies; antihistamines
10/12/2006	US20060229311 Isatine derivatives with neurotrophic activity
10/12/2006	US20060226021 Mixture of oligomeric phenazinium compounds and acid bath for electrolytically depositing a copper deposit
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1709012A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
10/11/2006	EP1709011A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/11/2006	CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors
10/11/2006	CN1845909A Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/11/2006	CN1844120A Aryl piperazine modified benzo [b] thiophene compounds and their preparation method and use
10/11/2006	CN1844106A Alkyl pyrazine phenolsulfonate and its preparation method and use
10/11/2006	CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use
10/10/2006	US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes
10/10/2006	US7119094 Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
10/10/2006	US7119091 Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/05/2006	WO2006104177A1 Organometallic complex, and light-emitting device and electronic appliance using the same
10/05/2006	WO2006102760A1 Inhibitors of histone deacetylase
10/05/2006	WO2006007496A3 Mitotic kinesin inhibitors
10/05/2006	WO2006004684A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/05/2006	WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006	US20060223830 Serotonin reuptake inhibitor and/or NeuroKinin 1 antagonist; 1-[(1RS)-1-(3,5-dibromobenzyloxymethyl)indan-1-yl]piperazine; depression; anxiety; nausea and gastrointestinal disorders; dementias; inflammation; pain; stress etc.
10/05/2006	US20060223829 such as 1-Phenyl-4-(m-tolylsulfonyl)piperazine, used in the treatment of type-2 diabetes, osteoporosis, hypertension, ocular disorders, cognitive disorders, the metabolic syndrome and other metabolic disorders
10/05/2006	US20060223793 Use of dopamine d3 receptor ligands for the production of drugs for treating renal function disorders

1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 187